Today, we announced that we will be presenting a poster at ASM Microbe 2024, taking place from June 13-17, 2024, at the Georgia World Congress Center in Atlanta. Read the full press release here: https://lnkd.in/gXwyyz2n American Society for Microbiology
Cidara Therapeutics’ Post
More Relevant Posts
-
Ph.D| Human Gut Microbiome | Bioinformatics| Host genetics| Molecular virology| NGS| Immunogenetics | Infectious diseases
As we learn from past outbreaks we need to also redirect research to the right areas. We focus on emerging and re-emerging pathogens due to climate change with an eye on zoonotic diseases jumping from wildlife, what of the domestic animals??
Inaugural Chair, Department of Global and Public Health, McGill University & Editor-in-Chief, PLOS Global Public Health Views reflect my own, not my institutions
Fully agree with this Nature Microbiology editorial! "To successfully tackle the current mpox public-health emergency, we must learn from past outbreaks to focus research questions and take collaborative action" https://lnkd.in/eJ7W-qDN
To view or add a comment, sign in
-
Cancer Research Intern @Tata memorial Centre - ACTREC (Navi Mumbai) B.Tech Biotechnology| undergraduate researcher | @ Medical Biotechnology | AMR | Oncogenesis | proteomics
I'm so excited to see that bacteriophages and phage therapy are finally receiving the advocacy and enthusiasm they deserve, highlighting their immense potential! A recent article published in Nature: https://lnkd.in/eCrBgHyW As an undergraduate researcher with a strong passion for bacteriophage therapy, I've been involved in projects focusing on the isolation and characterization of phages and developing combination cocktails for various multi-drug resistant bacterial strains, including those causing urinary tract infections, bovine mastitis, and periodontitis. The journey has been incredibly rewarding, and I look forward to contributing further to this exciting field! Superheroes Against Superbugs Superheroes against Superbugs I see a lot of potential in bacteriophage therapy, particularly in its ability to: - Target specific bacterial strains. - Reduce the risk of antibiotic resistance. - Offer personalized treatment options. Hélène BATINA ma'am Why'd you ruin the finale episode for me. T__T #Bacteriophages #PhageTherapy #AntibioticResistance #Research #Biotechnology #Microbiology
🔎Consultante en recrutement scientifique 👩🏾🔬 Ingénieure en biologie moléculaire microbienne 👐🏾Bénévole association BiotechnoSud
✨️"𝐀𝐝𝐯𝐨𝐜𝐚𝐭𝐢𝐧𝐠 𝐟𝐨𝐫 𝐩𝐡𝐚𝐠𝐞 𝐭𝐡𝐞𝐫𝐚𝐩𝐲" ✨️ (Editorial) "Personalized bacteriophage therapy outcomes for 100 consecutive cases: a multicentre, multinational, retrospective observational study" Jean-Paul Pirnay (Article) 👉🏾 📄 in Nature microbiology, June2024 ! 💡 Explore the advantages and limitations of phage therapy in this article! #phagetherapy: one of the key tools in the fight against bacterial antibiotic resistance "What is clear is that the development of therapeutic phages will require a coordinated effort of multiple stakeholders not limited to researchers, clinicians, funders, regulatory bodies and governments" https://lnkd.in/dypvQ7NV 📺 And if, like me, you're also a fan (huge binge watcher here🙋🏾♀️!) of TV shows you'll see that phages have even been featured in a mainstream series: The good doctor S07E10 (season finale) ‐----------Spoiler alert!‐--------- Using phage therapy against Acinetobacter infection to cure one of the main character !
To view or add a comment, sign in
-
#AMR #Sepsis #phagetherapy Those who find it difficult to combat AMR-infections may find this article in Nature and its editorial inspiring: Bacteriophages are no longer labelled "promising" in the battle against AMR-tsunami, they are "mandatory", says François Mayer, chief Editor of Nature Magazine. If clinicians find it difficult to press biologicals combating other biologicals into fixed RCT-study designs, which were drafted for chemical formulas only, this is no real surprise. But this doesn't mean we know nothing about efficacy and safety of phages, which multiple case reports, above all the recent BT100-study, show. Combined with the facts known from microbiology, one would say: Evidence is everywhere! Just grab it and stop people's suffering. Research will catch up with all still unknown details, and we'll improve phagetherapy still further, I'm very sure.
In our recent Editorial in Nature Microbiology, we advocate for phage therapy as a strategy to combat the global rise of antimicrobial resistance. https://lnkd.in/eCrBgHyW
To view or add a comment, sign in
-
What's going on with measles, the bird flu, and laboratory-developed tests? Listen to Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, and Bill Morice, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, discuss the latest updates in this episode of "Answers From the Lab." https://bit.ly/45pLSq3
Infectious Diseases on the Move: Bill Morice, M.D., Ph.D.
To view or add a comment, sign in
-
Meet University of Massachusetts Amherst undergraduate researcher Adam Charest, a microbiology and German major. His research in the Riley Lab seeks to find effective antibiotic alternatives to treat acne. He does this by highjacking naturally occurring antimicrobial peptides—known as bacteriocins—produced by bacteria, in order to fight other pathogenic bacteria. Learn how he got involved in the Riley Lab, what he’s learned from the experience, and how you can get involved in research. #RisingResearchers #UMassAmherst #UMassAmherstResearch #AntibioticResistance
To view or add a comment, sign in
-
🧪 Big congratulations to Astek Diagnostics! They have secured a $991,832 award from the National Science Foundation (NSF) under the Small Business Innovation Research Program Phase II. Their project focuses on developing a rapid antibiotic susceptibility testing (AST) platform that can deliver results in under an hour, addressing critical conditions like UTIs, urosepsis, and bacterial meningitis. #SBIR #Healthcare #Diagnostics 💡 This Cooperative Agreement will last for 24 months, starting on September 15, 2024, and ending on August 31, 2026. The research aims to significantly reduce the empirical use of broad-spectrum antibiotics, thereby combating the growing issue of antibiotic resistance. #R&D #Antibiotics #Innovation
To view or add a comment, sign in
-
#sampling #samplecollection #sampletransport #lbm #floqswabs #swab #science #collection #clinicalsamples #studies #clinicalmicrobiology #microbiology #microbiome #environment #hpv #still
Would you like to know more about the science behind our products? Copan's scientific affairs team will attend symposia and poster presentations across the #ECCMID venue. Still, Simone Paghera, Cristiano Sabelli, Ph.D., Stefania Di Costanzo, PhD, Anna Franzoni, and Chiara Senti will also be available at our booth for any of your scientific questions. Let's discuss pilot studies, trials, and product validations at booth D19! Discover everything about Copan at ECCMID by clicking the link below⤵️ https://lnkd.in/dE82jppm ESCMID - European Society of Clinical Microbiology and Infectious Diseases #Microbiology
To view or add a comment, sign in
-
🔎Consultante en recrutement scientifique 👩🏾🔬 Ingénieure en biologie moléculaire microbienne 👐🏾Bénévole association BiotechnoSud
✨️"𝐀𝐝𝐯𝐨𝐜𝐚𝐭𝐢𝐧𝐠 𝐟𝐨𝐫 𝐩𝐡𝐚𝐠𝐞 𝐭𝐡𝐞𝐫𝐚𝐩𝐲" ✨️ (Editorial) "Personalized bacteriophage therapy outcomes for 100 consecutive cases: a multicentre, multinational, retrospective observational study" Jean-Paul Pirnay (Article) 👉🏾 📄 in Nature microbiology, June2024 ! 💡 Explore the advantages and limitations of phage therapy in this article! #phagetherapy: one of the key tools in the fight against bacterial antibiotic resistance "What is clear is that the development of therapeutic phages will require a coordinated effort of multiple stakeholders not limited to researchers, clinicians, funders, regulatory bodies and governments" https://lnkd.in/dypvQ7NV 📺 And if, like me, you're also a fan (huge binge watcher here🙋🏾♀️!) of TV shows you'll see that phages have even been featured in a mainstream series: The good doctor S07E10 (season finale) ‐----------Spoiler alert!‐--------- Using phage therapy against Acinetobacter infection to cure one of the main character !
To view or add a comment, sign in
-
I love that this Nature article dives into future implementation of personalized #phage therapies. Do you think personalized phage preparation onsite in hospital pharmacies is the most likely future approach, or off-site library matching and production that is then delivered to the hospital/patient? #bacteriophage
🔎Consultante en recrutement scientifique 👩🏾🔬 Ingénieure en biologie moléculaire microbienne 👐🏾Bénévole association BiotechnoSud
✨️"𝐀𝐝𝐯𝐨𝐜𝐚𝐭𝐢𝐧𝐠 𝐟𝐨𝐫 𝐩𝐡𝐚𝐠𝐞 𝐭𝐡𝐞𝐫𝐚𝐩𝐲" ✨️ (Editorial) "Personalized bacteriophage therapy outcomes for 100 consecutive cases: a multicentre, multinational, retrospective observational study" Jean-Paul Pirnay (Article) 👉🏾 📄 in Nature microbiology, June2024 ! 💡 Explore the advantages and limitations of phage therapy in this article! #phagetherapy: one of the key tools in the fight against bacterial antibiotic resistance "What is clear is that the development of therapeutic phages will require a coordinated effort of multiple stakeholders not limited to researchers, clinicians, funders, regulatory bodies and governments" https://lnkd.in/dypvQ7NV 📺 And if, like me, you're also a fan (huge binge watcher here🙋🏾♀️!) of TV shows you'll see that phages have even been featured in a mainstream series: The good doctor S07E10 (season finale) ‐----------Spoiler alert!‐--------- Using phage therapy against Acinetobacter infection to cure one of the main character !
To view or add a comment, sign in
6,287 followers